Global Peripheral Interventions Market

Global Peripheral Interventions Market Definition & Scope The Global Peripheral Interventions Market, valued at USD 10.93 Billion in 2025, is projected to reach USD 28.86 Billion by 2036, expanding at a CAGR of 9.23% during the forecast period. Peripheral interventions are minimally invasive endovascular procedures that are used to diagnose and treat vascular disorders of arteries and veins outside the heart and brain. These procedures use specialized devices like angioplasty balloons, stents, atherectomy devices, embolic protection devices, catheters and guidewires to restore blood flow, remove plaque, repair aneurysms and manage peripheral vascular diseases with reduced surgical trauma and faster patient recovery. The market caters to a wide spectrum of applications such as peripheral artery disease (PAD), venous thromboembolism (VTE), aneurysm repair, carotid artery disease, and other peripheral vascular conditions across hospitals, surgical centers, ambulatory surgical centers, and specialty clinics. The market is seeing strong growth due to a rising incidence of peripheral artery disease, diabetes, obesity, hypertension and an aging global population that is more prone to vascular disorders. Market growth is driven by increasing preference for minimally invasive procedures, technological advancements in endovascular devices, increasing adoption of drug-coated balloons and advanced stent technologies and rising awareness for early vascular disease diagnosis. With the World Health Organization (WHO) reporting cardiovascular diseases to be the leading cause of death globally, the need for effective peripheral vascular interventions has never been more critical. The global peripheral interventions market is anticipated to grow considerably in the long-term during the forecast period, owing to continuous innovations in imaging-guided interventions, bioresorbable vascular scaffolds, intravascular ultrasound (IVUS), artificial intelligence-assisted procedural planning, robotic-assisted vascular interventions and next-generation catheter technologies. Global Peripheral Interventions Market: Key Highlights • The Global Peripheral Interventions Market was valued at USD 10.93 Billion in 2025, driven by the rising prevalence of peripheral artery disease (PAD), increasing incidence of diabetes and obesity, growing geriatric population, and expanding adoption of minimally invasive vascular procedures. • The market is projected to reach USD 28.86 Billion by 2036, expanding at a CAGR of 9.23% during 2026–2036. Growth is supported by continuous innovation in endovascular devices, increasing utilization of drug-coated balloons and advanced stent technologies, and expanding access to image-guided vascular interventions. • North America dominates the global market, accounting for an estimated 39.2% share in 2025. The region benefits from advanced cardiovascular care infrastructure, high procedural volumes, favorable reimbursement policies, strong physician adoption of minimally invasive interventions, and the presence of leading medical device manufacturers. • Asia Pacific is projected to register the fastest CAGR of 10.6% during 2026–2036, fueled by rising cardiovascular disease burden, expanding healthcare infrastructure, increasing awareness of peripheral vascular diseases, and growing investments in interventional radiology and vascular surgery across China, India, Japan, South Korea, and Southeast Asia. • Stents dominate the product type segment, accounting for an estimated 34.8% market share in 2025. The segment's leadership is attributed to widespread use in peripheral artery disease treatment, continuous technological advancements in drug-eluting and self-expanding stents, and favorable long-term clinical outcomes. • Atherectomy Devices are projected to register the fastest CAGR of 10.1% during the forecast period owing to increasing adoption for complex calcified lesions, growing preference for plaque removal procedures, and advancements in directional, orbital, rotational, and laser atherectomy technologies. • Peripheral Artery Disease (PAD) Treatment dominates the application segment with an estimated 46.3% share in 2025 due to the increasing prevalence of atherosclerosis, diabetes, smoking-related vascular disease, and the growing preference for minimally invasive endovascular therapies. • Venous Thromboembolism (VTE) is projected to witness the fastest CAGR of 9.9% during 2026–2036, driven by increasing awareness of venous disorders, rising incidence of deep vein thrombosis and pulmonary embolism, improved diagnostic capabilities, and expanding availability of catheter-based thrombectomy procedures. • Hospitals and Surgical Centers dominate the end-use segment, accounting for an estimated 68.7% share in 2025 owing to the availability of advanced imaging systems, hybrid operating rooms, multidisciplinary vascular care teams, and high volumes of complex endovascular procedures. • Ambulatory Surgical Centers are projected to register the fastest CAGR of 10.3% during the forecast period, supported by increasing migration of minimally invasive vascular procedures to outpatient settings, shorter recovery times, cost-effective treatment models, and advancements in catheter-based intervention technologies. Research Scope & Methodology The study provides a holistic strategic analysis of the Global Peripheral Interventions Market for the forecast period 2026-2036. The report provides a complete review of market size, revenue forecast, competitive landscape, technological developments, regulatory updates, reimbursement trends and emerging investment opportunities that impact the global peripheral interventions industry. The evaluation covers the entire value chain from device development and manufacturing through distribution, clinical adoption, procedural technologies and end-user utilization in hospitals, ambulatory surgical centers and specialty clinics. The market is segmented by Product Type (Angioplasty Balloons, Stents, Atherectomy Devices, Embolic Protection Devices, Catheters & Guidewires, Others), Application (Peripheral Artery Disease Treatment, Venous Thromboembolism, Aneurysm Repair, Carotid Artery Disease, Others), and End Use (Hospitals and Surgical Centers, Ambulatory Surgical Centers, Specialty Clinics). The regional analysis covers North America, Europe, Asia Pacific, and LAMEA. It covers the prevalence of the disease, healthcare infrastructure, adoption of interventional cardiology, vascular surgery capabilities, reimbursement policies, and regulatory factors affecting the growth of the market in these regions. The report also covers the latest developments in drug-coated technologies, bioresorbable vascular scaffolds, intravascular ultrasound (IVUS), optical coherence tomography (OCT), imaging powered by artificial intelligence, interventions assisted by robots, and the next generation of catheter technologies that continue to shape the competitive landscape of the peripheral interventions market. Our research methodology combines an exhaustive primary and secondary research to provide a reliable market intelligence and a robust long-term forecasting. Primary research includes structured interviews with interventional cardiologists, vascular surgeons, interventional radiologists, hospital administrators, medical device manufacturers, distributors, regulatory experts and healthcare industry consultants in major global markets. Secondary research includes publications by international healthcare organizations, government agencies, annual reports, investor presentations, scientific journals, regulatory databases, cardiovascular associations, and verified market intelligence sources. Market estimates are derived from a combination of top-down and bottom-up approaches. Data triangulation is achieved by using both approaches to validate the data across all segments and regional markets. Forecast models incorporate historical procedural volumes, prevalence of cardiovascular disease, healthcare expenditure, technological innovation, reimbursement trends, demographic shifts and uptake of minimally invasive therapies. Competitive benchmarking is employed to evaluate the product portfolios, research and development expenditures, clinical evidence, manufacturing capabilities, regulatory approvals, strategic partnerships, geographic presence, and commercialization strategies of key market participants. The aim is to offer a comprehensive understanding of the evolving competitive landscape in the Global Peripheral Interventions Market. Key Market Segments By Product Type: Angioplasty Balloons Stents Atherectomy Devices Embolic Protection Devices Catheters & Guidewires Others By Application: Peripheral Artery Disease Treatment Venous Thromboembolism Aneurysm Repair Carotid Artery Disease Others By End Use: Hospitals and Surgical Centers Ambulatory Surgical Centers Specialty Clinics Key Market Players Abbott Laboratories Boston Scientific Corporation Terumo Corporation B. Braun Melsungen AG Teleflex Incorporated Merit Medical Systems Inc. MicroPort Scientific Corporation AngioDynamics Inc. BD Bard Peripheral Vascular Inc. Cardiovascular Systems Inc. Industry Trends • Minimally invasive endovascular procedures are replacing traditional open vascular surgery due to shorter hospital stays, faster patient recovery, lower complication rates and reduced healthcare costs. Physicians are increasingly favoring catheter-based interventions, and this is driving continued demand for advanced peripheral intervention devices in hospitals and ambulatory surgical centers. • Drug-coated balloons (DCBs) and drug-eluting stents (DES) are increasingly employed in the treatment of peripheral artery disease. These technologies are increasingly favored for complex vascular procedures as they reduce restenosis, improve long-term vessel patency and minimize repeat interventions. • Atherectomy is a rapidly evolving field with the new generation of directional, rotational, orbital and laser atherectomy systems. These devices can successfully modify plaque in heavily calcified peripheral arteries, increasing procedural success rates and facilitating optimal stent deployment. • The sophistication of image-guided interventions is being enhanced by integration of intravascular ultrasound (IVUS), optical coherence tomography (OCT) and advanced angiographic imaging. Better visualization allows for better lesion assessment, device selection and treatment planning, leading to better procedural accuracy and patient outcomes. • Artificial intelligence (AI) is emerging as a useful tool in image analysis, lesion characterization, procedural guidance and predictive clinical decision-making in planning vascular intervention. AI-assisted technologies will help make procedures more efficient and optimize treatment strategies for complex peripheral vascular diseases. • Bioresorbable vascular scaffolds and next-generation biomaterials are gaining more and more interest and investment in research and development. These novel technologies are designed to provide temporary support to the vessel, while slowly dissolving after healing, potentially lowering long-term implant-related complications and improving vascular function. • The volume of peripheral vascular procedures performed in ambulatory surgical centers (ASCs) is growing due to advances in minimally invasive techniques, improved device safety, and favorable reimbursement models. Outpatient settings are increasingly being considered for selected vascular interventions that need short recovery. • Patient-specific treatment planning, precision imaging and tailored device selection based on lesion characteristics, vessel anatomy and individual risk profiles are progressing personalized vascular care. This results in better procedural outcomes and supports more targeted treatment approaches. • There is a growing emphasis on early diagnosis of peripheral artery disease through improved screening programs and non-invasive vascular imaging, which is resulting in a larger pool of patients who can be helped by timely endovascular intervention. Early treatment is helping to control the progression of the disease and lower the risk of major cardiovascular complications. • Strategic collaborations among medical device manufacturers, healthcare providers, research institutions, and digital health companies continue to accelerate innovations across the market. The long-term growth of the global peripheral interventions market is likely to be driven by investments in advanced imaging technologies, robotic-assisted interventions, artificial intelligence, next-generation stents, and catheter-based therapeutic platforms. Market Determinants • Rising Prevalence of Peripheral Artery Disease and Cardiovascular Disorders: The increasing prevalence of peripheral artery disease (PAD), diabetes, hypertension, obesity and the aging population across the globe is one of the major factors driving the peripheral interventions market. As the number of patients with vascular disorders continues to grow, so does the need for minimally invasive endovascular procedures that re-establish blood flow, ease symptoms and lower the risk of limb loss and cardiovascular complications. • Growing Preference for Minimally Invasive Vascular Procedures: Healthcare providers and patients are increasingly preferring catheter-based peripheral interventions over conventional open surgery owing to shorter hospital stays, lower procedural risks, rapid recovery, lower healthcare costs, and better clinical outcomes. This transition also propels the use of angioplasty balloons, stents, atherectomy devices and embolic protection systems. • Continuous Technological Advancements in Endovascular Devices: The development of drug-coated balloons, drug-eluting stents, atherectomy devices, embolic protection devices, intravascular imaging, guidewire systems, and catheter design continues to improve procedural accuracy, long-term vessel patency, and patient safety. These advances are broadening the armamentarium for more complex vascular lesions. • Expansion of Advanced Vascular Care Infrastructure: Greater investments in catheterization laboratories, hybrid operating rooms, interventional radiology departments, and vascular surgery centers are driving increased procedural volumes across the globe. Diagnostic imaging, physician training and healthcare infrastructure improvements in developed and emerging economies are driving the market growth. • High Cost of Advanced Peripheral Intervention Devices: Stents, atherectomy systems, embolic protection devices and imaging technologies in the premium price range make a large impact on the cost of procedures. The budget restrictions among the healthcare providers, especially in the developing economies can hinder the adoption of advanced endovascular technologies and thus impact the overall market penetration. • Stringent Regulatory Requirements and Reimbursement Challenges: Peripheral interventional devices are subject to strict clinical evaluation, regulatory approval and post-market surveillance before their commercialization. Variability in reimbursement policies, regulatory compliance requirements, and clinical evidence standards by country can lead to delays in product launches and influence physician adoption of novel vascular technologies Opportunity Mapping Based on Market Trends • Expansion of Peripheral Artery Disease Screening and Early Intervention Programs: Growing awareness of peripheral artery disease (PAD), increasing vascular screening initiatives, and improved access to non-invasive diagnostic imaging are creating significant opportunities for peripheral intervention device manufacturers. Earlier diagnosis enables timely minimally invasive treatment, increasing procedural volumes and demand for advanced angioplasty balloons, stents, atherectomy devices, and guidewire systems. • Advancements in Image-Guided and Artificial Intelligence-Assisted Interventions: Integration of artificial intelligence (AI), intravascular ultrasound (IVUS), optical coherence tomography (OCT), and advanced angiographic imaging is creating new growth opportunities across the market. These technologies improve lesion assessment, procedural planning, device selection, and treatment precision, enabling better clinical outcomes and supporting wider adoption of complex endovascular interventions. • Growing Adoption of Outpatient Vascular Procedures: The increasing migration of peripheral interventions from hospitals to ambulatory surgical centers (ASCs) presents substantial opportunities for manufacturers developing minimally invasive, cost-effective, and procedure-efficient vascular devices. Advances in catheter-based technologies and improved safety profiles are enabling a broader range of interventions to be performed in outpatient settings with shorter recovery times and lower healthcare costs. • Healthcare Infrastructure Expansion in Emerging Economies: Rising investments in cardiovascular care, expanding catheterization laboratories, increasing availability of interventional radiology services, and growing healthcare expenditure across Asia Pacific, Latin America, the Middle East, and Africa are creating favorable conditions for long-term market growth. Increasing physician training, improving access to advanced vascular technologies, and rising awareness of minimally invasive treatment options are expected to accelerate adoption of peripheral intervention devices throughout these rapidly developing regions. Value-Creating Segments and Growth Pockets Advanced Stent Technologies and Growing Minimally Invasive Procedures Sustain Stent Market Leadership Stents are projected to account for the largest market share of approximately 34.8% in 2025, supported by increasing adoption in peripheral artery disease treatment, continued development of self-expanding and drug-eluting stent technologies, improved long-term vessel patency, and growing physician preference for minimally invasive vascular reconstruction. Advances in stent design, materials, drug delivery, and deployment systems are improving procedural outcomes while expanding treatment options for patients with complex peripheral lesions. The growing prevalence of vascular diseases and increasing adoption of endovascular approaches over more invasive surgical procedures are further supporting demand. Continued innovation in stent technologies and peripheral revascularization is expected to sustain the segment's market leadership. The Atherectomy Devices segment is projected to register the highest CAGR of 10.1% during 2026–2036, driven by increasing treatment of severely calcified vascular lesions, growing use of plaque modification before stent placement, and continued technological advancements in directional, orbital, rotational, and laser atherectomy systems. Atherectomy enables physicians to modify or remove plaque and improve vessel preparation before balloon angioplasty or stent deployment, particularly in complex and heavily calcified lesions. Increasing adoption of lesion-specific treatment strategies and improvements in device precision and procedural safety are further expanding clinical utilization. Continued innovation in plaque modification technologies is expected to accelerate segment growth. Rising Vascular Disease Burden and Minimally Invasive Revascularization Sustain PAD Treatment Leadership Peripheral Artery Disease (PAD) Treatment is projected to account for the largest market share of approximately 46.3% in 2025, supported by the increasing incidence of atherosclerosis, diabetes, smoking-related vascular disease, and aging populations requiring minimally invasive revascularization procedures. Growing prevalence of peripheral vascular disease is increasing the number of patients requiring endovascular treatment, while advances in angioplasty balloons, drug-coated technologies, stents, and lesion-crossing devices are improving treatment options. Physicians are increasingly adopting catheter-based interventions to restore blood flow while reducing procedural invasiveness and recovery time. Continued innovation in peripheral revascularization technologies and increasing awareness of vascular disease are expected to sustain PAD treatment as the leading application segment. The Venous Thromboembolism (VTE) segment is projected to register the highest CAGR of 9.9% during 2026–2036, driven by increasing awareness of deep vein thrombosis and pulmonary embolism, advances in diagnostic imaging, growing adoption of catheter-directed thrombectomy procedures, and greater emphasis on early intervention. Healthcare providers are increasingly adopting minimally invasive approaches for selected patients with significant thrombotic burden, particularly as catheter technologies become more sophisticated. Improved imaging and procedural guidance are also enabling more targeted treatment of venous thromboembolic conditions. Continued innovation in thrombectomy systems and growing emphasis on reducing complications associated with untreated or severe VTE are expected to accelerate segment growth. Advanced Interventional Infrastructure and High Procedural Volumes Reinforce Hospital Market Leadership Hospitals and Surgical Centers are projected to account for the largest market share of approximately 68.7% in 2025, supported by advanced catheterization laboratories, hybrid operating rooms, multidisciplinary vascular care teams, sophisticated imaging systems, and high procedural volumes for complex peripheral vascular interventions. Hospitals typically have the infrastructure and specialized expertise required to manage patients with advanced vascular disease and perform complex endovascular procedures. Increasing integration of imaging, navigation, and catheter-based technologies is further strengthening their ability to provide comprehensive peripheral vascular care. Continued investment in advanced interventional facilities and increasing demand for minimally invasive vascular procedures are expected to sustain hospitals and surgical centers as the dominant end-use segment. Ambulatory Surgical Centers are projected to register the highest CAGR of 10.3% during 2026–2036, driven by the increasing shift of minimally invasive vascular procedures toward outpatient settings, shorter recovery times, lower procedural costs, favorable reimbursement trends, and advancements in catheter-based intervention technologies. Improvements in device safety, procedural efficiency, and patient selection are making an expanding range of peripheral interventions suitable for same-day or short-stay treatment. Healthcare providers are also seeking lower-cost care pathways while maintaining procedural quality and patient outcomes. Continued development of compact imaging systems, advanced catheters, and efficient outpatient workflows is expected to accelerate adoption of peripheral interventions in ambulatory surgical centers. Regional Market Assessment Advanced Vascular Care Infrastructure and Minimally Invasive Adoption Sustain North America's Market Leadership North America is projected to account for approximately 39.2% of the global peripheral interventions market in 2025, supported by sophisticated cardiovascular care infrastructure, high adoption of minimally invasive vascular procedures, favorable reimbursement frameworks, and the strong presence of leading medical device manufacturers. The United States represents the dominant regional market, driven by the high prevalence of peripheral artery disease (PAD), an expanding geriatric population, extensive use of image-guided interventions, and continued investment in catheterization laboratories and hybrid operating rooms. Increasing adoption of drug-coated technologies, intravascular imaging, advanced atherectomy systems, and robotic-assisted vascular procedures is further expanding treatment capabilities. Continued investment in vascular care infrastructure and procedural innovation is expected to sustain North America's market leadership. Advanced Endovascular Technologies and Physician Expertise Strengthen Europe's Peripheral Intervention Market Europe represents a significant market for peripheral interventions, supported by well-developed cardiovascular care systems, increasing awareness of peripheral vascular diseases, and widespread acceptance of minimally invasive endovascular therapies. Countries including the United Kingdom, Germany, France, Italy, and Spain continue to invest in advanced vascular imaging technologies, drug-coated balloons, atherectomy systems, and specialized vascular treatment centers. Growing physician expertise and established clinical guidelines are also encouraging the adoption of evidence-based interventional approaches. Increasing emphasis on earlier diagnosis and minimally invasive management of vascular conditions is further supporting procedural volumes. Continued technological advancement and development of specialized vascular care infrastructure are expected to drive sustained regional market growth. Expanding Cardiovascular Infrastructure and Endovascular Access Accelerate Asia Pacific Growth Asia Pacific is projected to register the highest CAGR of 10.6% during 2026–2036, driven by the rising prevalence of cardiovascular diseases, expanding healthcare infrastructure, increasing healthcare expenditure, and growing availability of interventional cardiology and vascular surgery services across China, India, Japan, South Korea, and Southeast Asia. Improvements in diagnostic capabilities and greater access to specialized vascular care are enabling more patients to receive minimally invasive interventions. Government initiatives focused on improving cardiovascular disease management, combined with increasing private-sector investment in hospitals and advanced imaging infrastructure, are further supporting market development. Growing adoption of drug-coated devices, atherectomy systems, and other advanced endovascular technologies is expected to accelerate regional growth. Healthcare Modernization and Improved Access to Vascular Care Create LAMEA Opportunities LAMEA is emerging as a promising market for peripheral interventions, supported by developing healthcare infrastructure, increasing awareness of vascular diseases, improving access to minimally invasive procedures, and rising investments in cardiovascular care. Countries including Brazil, Mexico, Saudi Arabia, the United Arab Emirates, and South Africa are strengthening interventional radiology and vascular treatment capabilities through specialized centers, advanced imaging systems, and improved access to medical technologies. Increasing diagnosis of peripheral vascular conditions and growing physician familiarity with endovascular procedures are further expanding the addressable patient population. Continued healthcare modernization and investments in specialized vascular services are expected to create long-term growth opportunities across the region. Recent Developments • May 2025: Boston Scientific Corporation expanded its peripheral vascular portfolio with advanced drug-coated balloon and atherectomy technologies designed to improve treatment outcomes for complex peripheral artery disease. • March 2025: Abbott Laboratories introduced enhanced peripheral intervention solutions incorporating advanced stent technologies and imaging integration to support more precise endovascular procedures. • October 2024: Terumo Corporation expanded its catheter and guidewire portfolio with next-generation devices engineered to improve navigation, procedural efficiency, and clinical outcomes during peripheral vascular interventions. • July 2024: Merit Medical Systems Inc. strengthened its vascular intervention product portfolio through new embolic protection and access technologies designed to enhance safety and efficiency in minimally invasive peripheral procedures. Critical Business Questions Addressed How will the Global Peripheral Interventions Market evolve through 2036? The report evaluates long-term market growth driven by increasing peripheral artery disease prevalence, expanding minimally invasive vascular procedures, technological innovation, and healthcare infrastructure development. Which product type, application, and end-user segments will generate the greatest commercial opportunities? The study identifies the dominant and fastest-growing market segments, enabling medical device manufacturers, healthcare providers, investors, and distributors to prioritize strategic investments. What are the primary factors driving market expansion? The report analyzes the influence of cardiovascular disease prevalence, aging populations, technological advancements in endovascular devices, image-guided interventions, and increasing adoption of minimally invasive procedures on future market development. Which regional markets present the strongest long-term investment potential? The assessment compares cardiovascular disease burden, healthcare infrastructure, reimbursement policies, physician adoption, and medical technology investments across major regions to identify the most attractive growth opportunities. How can peripheral intervention device manufacturers strengthen their competitive position in the evolving industry? The report examines strategic priorities including next-generation stent technologies, drug-coated devices, AI-assisted imaging, robotic-assisted interventions, product innovation, clinical evidence generation, and strategic partnerships to support long-term competitive advantage. Beyond the Forecast • The peripheral interventions market will increasingly benefit from advances in drug-coated technologies, intravascular imaging, artificial intelligence, robotic-assisted interventions, and next-generation catheter systems, enabling greater procedural precision and improved long-term patient outcomes. • Rising investments in cardiovascular disease prevention, early peripheral artery disease diagnosis, minimally invasive treatment programs, and outpatient vascular care will continue creating substantial opportunities for medical device manufacturers and healthcare providers across developed and emerging markets. • As healthcare systems prioritize minimally invasive therapies, precision vascular care, and advanced endovascular technologies, companies investing in innovative peripheral intervention devices, imaging-guided solutions, digital procedure planning, and physician training initiatives will be well positioned to capitalize on long-term growth opportunities in the global peripheral interventions market through 2036.